KRAS and cancer: Gene-set enrichment analysis has shown that important pathways are upregulated in response to SK1 knockdown in prostate and breast cancer cells, like KRAS, IL2/STAT5, EMT and TNF/NFκB [38], indicating that switching off one pathway is insufficient to completely block cancer cell growth.